Algorithms for the first-line management of bladder, bowel and sexual dysfunction in multiple sclerosis: Present and future.

Tota, Vito; Briganti, Giovanni; Ris, Laurence

doi:10.1016/j.msard.2024.105884

Article (Scientific journals)

Algorithms for the first-line management of bladder, bowel and sexual dysfunction in multiple sclerosis: Present and future.

Tota, Vito; Briganti, Giovanni; Ris, Laurence

2024 • In Multiple Sclerosis and Related Disorders, 91, p. 105884

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/20.500.12907/50576

DOI
10.1016/j.msard.2024.105884

PubMed
39321547

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

1-s2.0-S2211034824004607-main.pdf

Publisher postprint (964.61 kB)

Creative Commons License - Attribution, Non-Commercial, ShareAlike

Request a copy

All documents in ORBi UMONS are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Algorithms; Multiple sclerosis; Neurogenic bowel disorders; Neurogenic lower urinary tract dysfunction; Sexual dysfunction; Humans; Urinary Bladder, Neurogenic/therapy; Urinary Bladder, Neurogenic/etiology; Multiple Sclerosis/complications; Multiple Sclerosis/therapy; Sexual Dysfunction, Physiological/etiology; Sexual Dysfunction, Physiological/therapy; Sexual Dysfunction, Physiological; Urinary Bladder, Neurogenic; Neurology; Neurology (clinical)

Abstract :

[en] [en] INTRODUCTION: Neurogenic lower urinary tract (NLUTD), bowel (NBD), and sexual dysfunction (SD) are commonly observed in patients with (pw) multiple sclerosis (MS) and diminish the patients' quality of life (QoL). This systematic review aim to evaluate and discuss the current algorithms for the management of these issues. METHODS: A systematic review was conducted on the PubMed in June 2024. The primary search criterion was the presence of the term 'algorithm/s' or 'management/ing' in the title and/or abstract, followed by the MeSH term 'multiple sclerosis' and a combination of free-text keywords referring to NLUTD, NBD or SD. RESULTS: Fifteen articles regarding NLUTD were considered eligible, only one regarding SD while none addressed NBD. DISCUSSION: Numerous studies emphasize the profound impact of urinary and bowel symptoms on the QoL and morbidity in pwMS. Few algorithms addressing NLUTD are designed for first-line physicians and addresses the key priorities in MS care. Specific approaches to NBD management in pwMS are lacking. Screening for SD requires a structured assessment to deliver appropriate solutions. CONCLUSION: NLUTD, NBD, and SD are underdiagnosed and undertreated. The implementation of straightforward algorithms for first-line physicians could enhance the management of these common issues, improve the QoL, reduce costs, and ensure appropriate referral to specialists.

Disciplines :

Neurology

Author, co-author :

Tota, Vito ; Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Neurosciences

Briganti, Giovanni ; Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Médecine computationnelle et Neuropsychiatrie

Ris, Laurence ; Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Neurosciences

Language :

English

Title :

Algorithms for the first-line management of bladder, bowel and sexual dysfunction in multiple sclerosis: Present and future.

Publication date :

November 2024

Journal title :

Multiple Sclerosis and Related Disorders

ISSN :

2211-0348

eISSN :

2211-0356

Publisher :

Elsevier B.V., Netherlands

Volume :

Pages :

105884

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://api.elsevier.com/content/article/PII:S2211034824004607?httpAccept=text/xml

Research unit :

M119 - Neurosciences

Research institute :

R550 - Institut des Sciences et Technologies de la Santé

Funding text :

The funding sources had no role in the design of the study, data collection, analysis, interpretation of results, writing of the manuscript, or decision to publish. This publication acknowledges the financial support of the European Union and Wallonia through the FEDER program for the project titled \u201CMedReSyst_UMONS_AI for Brain\u201D.

Available on ORBi UMONS :

since 18 December 2024

Statistics

Number of views

3 (1 by UMONS)

Number of downloads

0 (0 by UMONS)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Abrams, P, Cardozo, L, Fall, M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol. Urodyn. 21:2 (2002), 167–178, 10.1002/nau.10052.
Amarenco, G, Chartier-Kastler, E, Denys, P, Jean, JL, De Sèze, M, Lubetzski, C, First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm. Mult. Scler. 19:14 (2013), 1931–1937, 10.1177/1352458513489758.
Andretta, E, Finazzi Agrò, E, Calabrese, M, Orecchia, L, Furlan, A, Zuliani, C, Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data. Ther. Adv. Urol., 14, 2022, 175628722211224, 10.1177/17562872221122484.
Barbalias, GA, Liatsikos, EN, Passakos, C, Barbalias, D, Sakelaropoulos, G., Urologic manifestations of multiple sclerosis: proposed treatment algorithms. Int. Urol. Nephrol. 32:3 (2001), 345–348, 10.1023/A:1017532631643.
Barin, L, Salmen, A, Disanto, G, et al. The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?. Mult. Scler. Relat. Disord. 25 (2018), 112–121, 10.1016/j.msard.2018.07.013.
Beck, J, Jaekel, AK, Zeller, FL, et al. Clinical predictors of neurogenic lower urinary tract dysfunction in persons with multiple sclerosis. Diagnostics, 12(1), 2022, 191, 10.3390/diagnostics12010191.
Bronner, G, Elran, E, Golomb, J, Korczyn, AD., Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol. Scand. 121:5 (2010), 289–301, 10.1111/j.1600-0404.2009.01314.x.
Browne, C, Salmon, N, Kehoe, M., Bladder dysfunction and quality of life for people with multiple sclerosis. Disability Rehabil. 37:25 (2015), 2350–2358, 10.3109/09638288.2015.1027007.
Buljevac, D, Flach, HZ, Hop, WCJ, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125:5 (2002), 952–960, 10.1093/brain/awf098.
Castel-Lacanal, E, Gamé, X, Clanet, M, et al. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients: Urinary Complications and Risk Factors in Multiple Sclerosis. Neurourol. Urodyn. 34:1 (2015), 32–36, 10.1002/nau.22495.
Castel-Lacanal, E, Gamé, X, Clanet, M, et al. Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis. Neurourol. Urodyn. 36:3 (2017), 706–709, 10.1002/nau.23002.
Çetinel, B, Tarcan, T, Demirkesen, O, et al. Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report. Neurourol. Urodyn. 32:8 (2013), 1047–1057, 10.1002/nau.22374.
Cotterill, N, Madersbacher, H, Wyndaele, JJ, et al. Neurogenic bowel dysfunction: clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013. Neurourol. Urodyn. 37:1 (2018), 46–53, 10.1002/nau.23289.
Darija, KT, Tatjana, P, Goran, T, et al. Sexual dysfunction in multiple sclerosis: a 6-year follow-up study. J. Neurol. Sci. 358:1–2 (2015), 317–323, 10.1016/j.jns.2015.09.023.
De Ridder, D, Van Der Aa, F, Debruyne, J, et al. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis. Clin. Neurol. Neurosurg. 115:10 (2013), 2033–2040, 10.1016/j.clineuro.2013.06.018.
De Sèze, M, Raibaut, P, Gallien, P, et al. Intérêt thérapeutique de la stimulation transcutanée tibiale postérieure dans les troubles mictionnels irritatifs de la sclérose en plaques. Résultats d'un programme de recherche clinique hospitalier multicentrique. Pelv. Perineol. 6:2 (2011), 80–88, 10.1007/s11608-010-0354-6.
De Sèze, M, Ruffion, A, Denys, P, Joseph, PA, Perrouin-Verbe B, International Francophone Neuro-Urological expert study group (GENULF). The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult. Scler. 13:7 (2007), 915–928, 10.1177/1352458506075651.
Di Benedetto, P, Delneri, C, Biasutti, E, Bragadin, LM, Giorgini, T., Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology. Neurol. Sci. 29:S4 (2008), 348–351, 10.1007/s10072-008-1041-z.
Dibley, L, Coggrave, M, McClurg, D, Woodward, S, Norton, C., “It's just horrible”: a qualitative study of patients’ and carers’ experiences of bowel dysfunction in multiple sclerosis. J. Neurol. 264:7 (2017), 1354–1361, 10.1007/s00415-017-8527-7.
Dinh, A, Davido, B, Duran, C, et al. Urinary tract infections in patients with neurogenic bladder. Méd. Mal. Infectieuses 49:7 (2019), 495–504, 10.1016/j.medmal.2019.02.006.
Domurath, B, Kurze, I, Kirschner-Hermanns, R, et al. Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm. Mult. Scler. Relat. Disord., 44, 2020, 102248, 10.1016/j.msard.2020.102248.
Donzé, C, Hautecoeur, P., Troubles sphinctériens au stade precoce de la sclérose en plaques. Revue Neurol. 165 (2009), S148–S155, 10.1016/S0035-3787(09)72127-7.
Donzé, C, Papeix, C, Dinh, A, et al. Recommandations de la Société française de la sclérose en plaques « infections urinaires et sclérose en plaques » : aspects pratiques. Pratique Neurol. FMC 11:3 (2020), 196–201, 10.1016/j.praneu.2020.07.001.
Fletcher, SG, Castro-Borrero, W, Remington, G, Treadaway, K, Lemack, GE, Frohman, EM, Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat. Rev. Urol. 6:2 (2009), 96–107, 10.1038/ncpuro1298.
Fletcher, SG, Dillon, BE, Gilchrist, AS, et al. Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Mult. Scler. 19:9 (2013), 1169–1174, 10.1177/1352458512474089.
Fowler, CJ, Panicker, JN, Drake, M, et al. A UK consensus on the management of the bladder in multiple sclerosis. Postgrad. Med. J. 85:1008 (2009), 552–559, 10.1136/jnnp.2008.159178.
Fowler, CJ., A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 76:5 (2005), 700–705, 10.1136/jnnp.2004.038695.
Ghezzi, A, Carone, R, et al., The Multiple Sclerosis Study Group, Italian Society of Neurology. Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group. Neurol. Sci. 32:6 (2011), 1223–1231, 10.1007/s10072-011-0794-y.
Ghezzi, A, Mutta, E, Bianchi, F, et al. Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances. Neurol. Sci. 37:3 (2016), 437–442, 10.1007/s10072-015-2415-7.
Glykas, I, Fragkoulis, C, Mitsikostas, DD, et al. B3 agonists or anticholinergics in the treatment of the lower urinary tract dysfunction in patients with multiple sclerosis?—A randomized study. World J. Urol. 39:8 (2021), 3049–3056, 10.1007/s00345-020-03555-8.
Hatzichristou, D, Kirana, PS, Banner, L, et al. Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires. J. Sex. Med. 13:8 (2016), 1166–1182, 10.1016/j.jsxm.2016.05.017.
Ingram, CF, Lincoln, JA, Khavari, R., Voiding phase dysfunction in multiple sclerosis. Urol. Clin. North Am. 51:2 (2024), 177–185, 10.1016/j.ucl.2024.01.005.
Kessler, TM, Fowler, CJ, Panicker, JN., Sexual dysfunction in multiple sclerosis. Expert Rev. Neurother. 9:3 (2009), 341–350, 10.1586/14737175.9.3.341.
Khalaf, KM, Coyne, KS, Globe, DR, et al. The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosis. Neurourol. Urodyn. 35:1 (2016), 48–54, 10.1002/nau.22670.
Khan, F, McPhail, T, Brand, C, Turner-Stokes, L, Kilpatrick, T., Multiple sclerosis: disability profile and quality of life in an Australian community cohort. Int. J. Rehab. Res. 29:2 (2006), 87–96, 10.1097/01.mrr.0000194393.56772.62.
Kurze, I, Geng, V, Böthig, R, Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease. Spinal Cord 60:5 (2022), 435–443, 10.1038/s41393-022-00786-x.
Lawrenson, R, Wyndaele, JJ, Vlachonikolis, I, Farmer, C, Glickman, S., Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 20:2 (2001), 138–143, 10.1159/000054774.
Li, V, Haslam, C, Pakzad, M, Brownlee, WJ, Panicker, JN., A practical approach to assessing and managing sexual dysfunction in multiple sclerosis. Pract. Neurol. 20:2 (2020), 122–131, 10.1136/practneurol-2019-002321.
Marzouk, MH, Darwish, MH, El-Tamawy, MS, Morsy, S, Abbas, RL, Ali, AS., Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study. Mult. Scler. Relat. Disord., 68, 2022, 104252, 10.1016/j.msard.2022.104252.
McClurg, D, Harris, F, Goodman, K, et al. Abdominal massage plus advice, compared with advice only, for neurogenic bowel dysfunction in MS: a RCT. Health Technol. Assess. 22:58 (2018), 1–134, 10.3310/hta22580.
Miget, G, Tan, E, Pericolini, M, et al. The Neurogenic Bowel Dysfunction score (NBD) is not suitable for patients with multiple sclerosis. Spinal Cord 60:12 (2022), 1130–1135, 10.1038/s41393-022-00837-3.
Morrow, SA, Rosehart, H, Sener, A, Welk, B., Anti-cholinergic medications for bladder dysfunction worsen cognition in persons with multiple sclerosis. J. Neurol. Sci. 385 (2018), 39–44, 10.1016/j.jns.2017.11.028.
Munteis, E, Andreu, M, Téllez, MJ, Mon, D, Ois, A, Roquer, J., Anorectal dysfunction in multiple sclerosis. Mult. Scler. 12:2 (2006), 215–218, 10.1191/135248506ms1254oa.
Musco, S, Padilla-Fernández, B, Del Popolo, G, et al. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: a systematic review. Neurourol. Urodyn. 37:5 (2018), 1522–1540, 10.1002/nau.23501.
Norton, C, Chelvanayagam, S., Bowel problems and coping strategies in people with multiple sclerosis. Br. J. Nurs. 19:4 (2010), 220–226, 10.12968/bjon.2010.19.4.46783.
Panayi, DC, Khullar, V, Digesu, GA, Spiteri, M, Hendricken, C, Fernando, R., Rectal distension: the effect on bladder function. Neurourol. Urodyn. 30:3 (2011), 344–347, 10.1002/nau.20944.
Panicker, JN, Fowler, CJ, Kessler, TM., Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 14:7 (2015), 720–732, 10.1016/S1474-4422(15)00070-8.
Panicker, JN, Marcelissen, T, Von Gontard, A, Vrijens, D, Abrams, P, Wyndaele, M., Bladder-bowel interactions: do we understand pelvic organ cross-sensitization? International Consultation on Incontinence Research Society (ICI-RS) 2018. Neurourol. Urodyn., 38(S5), 2019, 10.1002/nau.24111.
Phé, V, Chartier–Kastler, E, Panicker, JN, Management of neurogenic bladder in patients with multiple sclerosis. Nat. Rev. Urol. 13:5 (2016), 275–288, 10.1038/nrurol.2016.53.
Polat Dunya, C, Tulek, Z, Kürtüncü, M, Panicker, JN, Eraksoy, M, Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder. Mult. Scler. 27:4 (2021), 621–629, 10.1177/1352458520926666.
Preziosi, G, Gordon-Dixon, A, Emmanuel, A, Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies. DNND 8 (2018), 79–90, 10.2147/DNND.S138835.
Safarinejad, MR., Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J. Urol. 181:1 (2009), 252–258, 10.1016/j.juro.2008.09.003.
Safarinejad, MR., Expression of concern: evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J. Urol., 2023, 10.1097/JU.0000000000003114 Published online January 10.
Sanders, AS, Foley, FW, LaRocca, NG, Zemon, V., The multiple sclerosis intimacy and sexuality questionnaire-19 (MSISQ-19). Sex. Disability 18:1 (2000), 3–26, 10.1023/A:1005421627154.
Sarveazad, A, Babahajian, A, Amini, N, Shamseddin, J, Yousefifard, M., Posterior Tibial nerve stimulation in fecal incontinence: a systematic review and meta-analysis. Basic Clin. Neurosci. J., 2019, 419–432, 10.32598/bcn.9.10.290.
Schairer, LC, Foley, FW, Zemon, V, et al. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult. Scler. 20:5 (2014), 610–616, 10.1177/1352458513503598.
Schneider, MP, Tornic, J, Sýkora, R, et al. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS). Neurourol. Urodyn. 38:6 (2019), 1482–1491, 10.1002/nau.24039.
Seddone, S, Marturano, M, Bientinesi, R, et al. Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments. Neurourol. Urodyn. 40:6 (2021), 1500–1508, 10.1002/nau.24687.
Stoffel, JT., Contemporary Management of the Neurogenic Bladder for Multiple Sclerosis Patients. Urologic Clin. North Am. 37:4 (2010), 547–557, 10.1016/j.ucl.2010.06.003.
Tadayyon, F, Etemadifar, M, Bzeih, H, et al. Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females. J. Res. Med. Sci. 17:4 (2012), 382–385.
Tan, E, Turmel, N, Kerdraon, J, et al. A new tool to investigate anorectal disorders in patients with multiple sclerosis: STAR-Q. Progrès en Urologie 33:7 (2023), 362–369, 10.1016/j.purol.2023.02.006.
Thompson, AJ, Baranzini, SE, Geurts, J, Hemmer, B, Ciccarelli, O., Multiple sclerosis. The Lancet 391:10130 (2018), 1622–1636, 10.1016/S0140-6736(18)30481-1.
Tornic, J, Panicker, JN., The management of lower urinary tract dysfunction in multiple sclerosis. Curr. Neurol. Neurosci. Rep., 18(8), 2018, 54, 10.1007/s11910-018-0857-z.
Tudor, KI, Eames, S, Haslam, C, Chataway, J, Liechti, MD, Panicker, JN., Identifying barriers to help-seeking for sexual dysfunction in multiple sclerosis. J. Neurol. 265:12 (2018), 2789–2802, 10.1007/s00415-018-9064-8.
Tzortzis, V, Skriapas, K, Hadjigeorgiou, G, et al. Sexual dysfunction in newly diagnosed multiple sclerosis women. Mult. Scler. 14:4 (2008), 561–563, 10.1177/13524585080140040901.
Wang, G, Marrie, RA, Fox, RJ, et al. Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis. Multiple Scler. Relat. Disord. 20 (2018), 16–21, 10.1016/j.msard.2017.12.006.
Wang, T, Huang, W, Zhang, Y., Clinical characteristics and urodynamic analysis of urinary dysfunction in multiple sclerosis. Chin. Med. J. 129:6 (2016), 645–650, 10.4103/0366-6999.177970.
Yang, CC., Bladder management in multiple sclerosis. Phys. Med. Rehab. Clin. North Am. 24:4 (2013), 673–686, 10.1016/j.pmr.2013.06.004.
Zheng, YB, Shi, L, Zhu, XM, et al. Anticholinergic drugs and the risk of dementia: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 127 (2021), 296–306, 10.1016/j.neubiorev.2021.04.031.
Ziadeh, T, Mjaess, G, El Helou, J, et al. Impact on quality of life in multiple sclerosis patients: which urinary symptoms are to blame?. Progrès en Urologie 32:10 (2022), 711–716, 10.1016/j.purol.2022.05.003.